ANALYSIS OF RISK FACTORS IN PATIENTS WHO HAVE UNDERGONE CORONARY ARTERY BYPASS GRAFTING SURGERY AND VALVE REPLACEMENT SURGERY

Yıl 2019, Cilt: 6 Sayı: 2, 49 - 53, 01.06.2019

Fatih Erkan Atay , Begüm Söyleyici , Alperen Elibol , Pelinsu Elif Hünkar , Berfin Tan , Volkan Yüksel

Öz

Aims: The aim of the study is to investigate differences in usual cardiovascular risk factors’ and comorbidities between the patients who had undergone coronary artery bypass grafting surgery and valve replacement surgery at Cardiovascular Surgery
Department of Trakya University School of Medicine. Methods: In this study, patients who had coronary artery bypass grafting
surgery and valve replacement surgery at Cardiovascular Surgery Department of Trakya University School of Medicine between
01.01.2018 and 31.12.2018 were analyzed retrospectively. All data regarding the type of cardiovascular operation, habits of smoking, alcohol consumption, family history, chronic diseases and laboratory findings were analyzed using R version 3.5.0. Results:
The total number of patients in the study was 130. There were 106 patients who had coronary bypass grafting surgery, 90 (95.4%)
of them were male and 16 (4.6%) of them were female. The number of the patients who had valve replacement surgery was 24
where 15 (62.5%) of them were female and 9 (37.5%) were male. Differences in patients’ high-density lipoprotein levels, fasting
blood glucose levels along with gender, habits of smoking, diabetes mellitus status and alcohol consumption between coronary
artery bypass grafting surgery and valve replacement surgery groups were found statistically significant. Conclusion: Risk factors for cardiovascular disease are very dynamic and multifactorial. In our analysis, there was a significant difference between
risk factors for coronary artery bypass and valve replacement surgeries including high-density lipoprotein levels, fasting blood
glucose levels, diabetes mellitus, gender and smoking status. The variability may alter according to the living standards, culture,
educational status among patients. Keywords: Coronary disease, coronary artery, surgery, risk factors

Anahtar Kelimeler

Coronary disease, coronary artery, surgery

Kaynakça

• 1. Mendis S, Armstrong T, Bettcher D et al. Global status report on non-communicable diseases 2014. World Health Organization (WHO):2014.
• 2. Townsend N, Nichols M, Scarborough P et al. Cardiovascular disease in Europe-epidemiological update 2015. Eur Heart J 2015;36:2696-705.
• 3. Institute for Health Metrics and Evaluation (IHME). Findings from the Global Burden of Disease Study 2017. Seattle, WA: IHME, 2018.
• 4. Yeh RW, Sidney S, Chandra M et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362:2155–65.
• 5. Schoen FJ. Morphology, clinicopathologic correlations, and mechanisms in heart valve health and disease. Cardiovasc Eng Technol 2018;9:126-40.
• 6. Aikawa E, Schoen FJ. Calcified and degenerative heart valve disease. In: cellular and molecular basis of cardiovascular disease. Arterioscler Thromb Vasc Biol 2014;34:2387–93.
• 7. Schoen FJ, Mitchell RN. The heart. In: Kumar V, Abbas AK, Aster JC, editors. Robbins and Cotran pathologic basis of disease (Ninth edition). Philadelphia PA: Elsevier/Saunders; 2015.p.523–78.
• 8. Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981;40:1-52.
• 9. Dawber TR, Kandel WB, Revotskie N et al. The epidemiology of coronary heart disease - the Framingham enquiry. Proc R Soc Med 1962;55:265-71.
• 10. Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J 2010;18:598–602.
• 11. Yutzey KE, Demer LL, Body SC et al. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on calcific aortic valve disease. Arterioscler Thromb Vasc Biol 2014;34:2387–93.
• 12. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol 1997;29:630–4.
• 13. Kindo M, Hoang Minh T, Perrier S et al. Trends in isolated coronary artery bypass grafting over the last decade. Interactive CardioVascular and Thoracic Surgery, 2016;24:71–6.
• 14. Perez-Hernandez N, Vargas-Alacron G, Martinez-Rodriguez N et al. The matrix metalloproteinase 2-1575 gene polymorphism is associated with the risk of developing myocardial infarction in Mexican patients. J Atheroscler Thromb 2012;19:718-27.
• 15. Kapko WS, Krzych Ł. Knowledge on cardiovascular risk factors improves the effectiveness of rehabilitation following acute coronary syndrome. Kardiol Pol 2017;75:344-50.
• 16. Emral R. Diabetes mellitus and hyperlipidemia. Turkiye Klinikleri J Endocrin 2008;1:38-43.
• 17. Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Cardiol Clin 2014;32:439–55.
• 18. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997;315:973-80.
• 19. Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med 2014;12:182.
• 20. Wensley F, Gao P, Burgess S et al. Association between c reactive protein and coronary heart disease: mendelian randomization analysis based on individual participant data. BMJ 2011;342:548.
• 21. Inoue N. Stress and atherosclerotic cardiovascular disease. J Atheroscler Thromb 2014;21:391-401.
• 22. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 2002;23:51-61.
• 23. Wulsin LR, Single BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003;65:201-10.